home / stock / nlsp / nlsp quote
Last: | $0.1367 |
---|---|
Change Percent: | 7.1% |
Open: | $0.123 |
Close: | $0.1367 |
High: | $0.1464 |
Low: | $0.1211 |
Volume: | 437,027 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.1367 | $0.123 | $0.1367 | $0.1464 | $0.1211 | 437,027 | 04-26-2024 |
$0.1324 | $0.1346 | $0.1324 | $0.1346 | $0.1138 | 152,992 | 04-25-2024 |
$0.125 | $0.1201 | $0.125 | $0.1299 | $0.1201 | 39,613 | 04-24-2024 |
$0.1302 | $0.126 | $0.1302 | $0.135 | $0.1165 | 324,975 | 04-23-2024 |
$0.1299 | $0.1325 | $0.1299 | $0.139 | $0.113 | 573,774 | 04-22-2024 |
$0.1327 | $0.1325 | $0.1327 | $0.1405 | $0.1325 | 92,054 | 04-19-2024 |
$0.1327 | $0.1457 | $0.1327 | $0.1457 | $0.1322 | 96,906 | 04-18-2024 |
$0.133 | $0.14 | $0.133 | $0.1489 | $0.132 | 124,850 | 04-17-2024 |
$0.137 | $0.1485 | $0.137 | $0.1485 | $0.1311 | 279,376 | 04-16-2024 |
$0.1415 | $0.144 | $0.1415 | $0.1528 | $0.141 | 167,760 | 04-15-2024 |
$0.1496 | $0.1569 | $0.1496 | $0.1569 | $0.145 | 229,214 | 04-12-2024 |
$0.15355 | $0.15 | $0.15355 | $0.165 | $0.15 | 377,740 | 04-11-2024 |
$0.1496 | $0.1486 | $0.1496 | $0.165 | $0.145 | 135,621 | 04-10-2024 |
$0.1493 | $0.1474 | $0.1493 | $0.1546 | $0.1407 | 97,188 | 04-09-2024 |
$0.1406 | $0.1486 | $0.1406 | $0.1488 | $0.1315 | 348,956 | 04-08-2024 |
$0.1422 | $0.158 | $0.1422 | $0.158 | $0.1351 | 734,794 | 04-05-2024 |
$0.1542 | $0.16 | $0.1542 | $0.17 | $0.1518 | 401,103 | 04-04-2024 |
$0.16 | $0.1709 | $0.16 | $0.1709 | $0.1515 | 441,323 | 04-03-2024 |
$0.1759 | $0.17 | $0.1759 | $0.1814 | $0.16 | 235,106 | 04-02-2024 |
$0.1724 | $0.189 | $0.1724 | $0.1929 | $0.17 | 262,382 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
NLS Pharmaceutics Ltd. Company Name:
NLSP Stock Symbol:
NASDAQ Market:
ZÜRICH, SWITZERLAND / ACCESSWIRE / March 22, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervo...
A look at the top 10 most actives in the United States Fisker Inc. Class A (FSR) rose 0.1% to $0.1331 on volume of 235,074,479 shares Jaguar Health Inc. (JAGX) rose 16.0% to $0.0799 on volume of 189,600,392 shares BYND Cannasoft Enterprises Inc. (BCAN) rose 2.5% to $0.0205 on volume of 17...
ZURICH, SWITZERLAND / ACCESSWIRE / March 20, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous sy...